2026年5月19日至22日，欧洲介入心脏病学大会（EuroPCR 2026）即将在法国巴黎隆重召开！EuroPCR聚集了来自全球的介入心脏病专家、外科医师、影像医师以及护理人员等，在推动介入心脏病学发展与规范临床实践的过程中发挥了重要作用，已经成为了全球介入心脏病学领域的重要会议之一。EuroPCR 2026将比以往任何时候都更大，更有影响力！会议日程中设置了多场Hot Line/Late-Breaking Trials，涉及冠脉介入、结构性心脏病、药物球囊、腔内影像学、钙化病变处理、生理学指导、微血管功能评估等新技术、新器械、新理念，与全球介入心脏病学家们分享最新突破，共议临床进展。在众多最新临床研究中也不乏来自中国的优秀成果。下面，就让我们一起来看今年的新研究有哪些值得关注。

Major Late-Breaking Trials from EuroPCR 2026

北京时间：5月20日 15:45-16:45

Coronary revascularisation in patients undergoing TAVI: an IPD meta-analysis of four randomised trials
接受TAVI患者的冠状动脉血运重建：四项随机试验的个体患者数据荟萃分析

Long-term mortality following PCI with DES vs. CABG for left main disease
左主干病变PCI（DES） vs. CABG的长期死亡率

Outcomes of LAA closure vs. NOAC in patients with atrial fibrillation across different age groups
左心耳封堵 vs. NOAC用于房颤患者不同年龄组的结局

New evidence in the treatment of calcified lesions

北京时间：5月19日 18:00-19:00

Intravascular lithotripsy vs. cutting balloon by calcium type: IVUS substudy of the ShortCUT trial
按钙化类型对比血管内碎石术与切割球囊：ShortCUT试验的IVUS子研究

Prognostic significance of rotational atherectomy, intravascular lithotripsy and orbital atherectomy
旋磨术、血管内碎石术和轨道旋磨术的预后意义

Randomised comparison of orbital vs. rotational atherectomy on coronary microvascular function
轨道旋磨术 vs. 旋磨术对冠状动脉微血管功能的随机对照研究

Safety and efficacy of novel intravascular lithotripsy system for coronary calcium: FRACTURE study
新型血管内碎石系统治疗冠状动脉钙化的安全性与有效性：FRACTURE研究

Intravascular lithotripsy or rotational atherectomy for calcified coronary PCI: the ICARE trial 12-month clinical outcomes
血管内碎石术 vs. 旋磨术用于钙化冠状动脉PCI：ICARE试验12个月临床结局

Evidence for new devices in management of coronary artery disease

北京时间：5月19日 18:00-19:00

Impact of imaging, or physiology-guided PCI on outcomes with Bioadaptor from INFINITY-SWEDEHEART RCT
影像学指导或生理学指导的PCI对Bioadaptor结局的影响：INFINITY-SWEDEHEART RCT

Five-year outcomes of thinner-strut Firesorb bioresorbable scaffold in the FUTURE-II trial
更薄支架梁Firesorb生物可吸收支架的五年结局：FUTURE-II试验
中国医学科学院阜外医院 宋雷教授

Site-specific antithrombotic therapy: DESyne BDS Plus Trial 36-month outcomes
部位特异性抗栓治疗：DESyne BDS Plus试验36个月结果

Recurrent PCI at ten years after treatment with biodegradable vs. permanent Polymer DES
可降解 vs. 永久聚合物药物洗脱支架治疗后十年再次PCI的发生率

Percutaneous coronary treatment with Bioadaptor vs. stent: four-years outcomes from BIOADAPTOR-RCT
经皮冠状动脉治疗中Bioadaptor vs. 支架：BIOADAPTOR-RCT的四年结局

Outcomes in tricuspid valve intervention

北京时间：5月19日 21:00-22:00

The Cardiovalve replacement system for tricuspid regurgitation, TARGET study interim results
Cardiovalve 三尖瓣置换系统治疗三尖瓣反流：TARGET 研究中期结果

Clinical impact of atrial fibrillation on tricuspid TEER
房颤对三尖瓣 TEER 的临床影响

The less the better: mild vs. moderate residual tricuspid regurgitation after tricuspid TEER: insights from EuroTR
越少越好——三尖瓣 TEER 术后轻度 vs. 中度残余三尖瓣反流的临床影响：EuroTR 研究的见解

Afterload mismatch after transcatheter tricuspid intervention in the TriValve registry
经导管三尖瓣介入术后后负荷不匹配：TriValve 注册研究分析

Long-term outcomes of bioprosthetic valves in the tricuspid position: meta-analysis of over 20 year
生物瓣膜在三尖瓣位置的长期结局：超过20年的荟萃分析

New evidence for pharmacology for coronary artery disease

北京时间：5月19日 21:00-22:00

Evolocumab in patients with coronary stenting and no prior myocardial infarction: results from the VESALIUS-CV trial
依洛尤单抗用于冠状动脉支架植入且无既往心肌梗死患者：VESALIUS-CV 试验结果

Early aspirin cessation after PCI in AMI: stratification by ischemic risk from TARGET FIRST trial
AMI 患者 PCI 术后早期停用阿司匹林：TARGET FIRST 试验的缺血风险分层分析

Aspirin-free strategy after complex PCI in ACS: the NEO-MINDSET COMPLEX subanalysis
ACS 患者复杂 PCI 后无阿司匹林策略：NEO-MINDSET COMPLEX 子分析

Net outcomes of clopidogrel vs. aspirin after coronary stenting by bleeding risk and PCI complexity
冠状动脉支架术后按出血风险和 PCI 复杂度对比氯吡格雷与阿司匹林的净结局
中国医学科学院阜外医院 王浩宇教授

Innovative strategy in ACS

北京时间：3月29日 02:00-03:00

DCB in STEMI: multicentre international registry
STEMI中药物涂层球囊的应用：多中心国际注册研究

Safety of early discharge using index of microcirculatory resistance after primary PCI
使用微循环阻力指数评估直接 PCI 术后早期出院的安全性

Safety and effectiveness of coronary intravascular lithotripsy in ACS patients: real-world registry data
冠状动脉血管内碎石术在 ACS 患者中的安全性与有效性：真实世界注册数据

CTA plus CTP: guided initial evaluation vs. routine care for low-risk suspected NSTEMI （the SMART study）
CTA 联合CTP指导的初始评估 vs. 常规治疗用于低风险疑似 NSTEMI（SMART 研究）
Wei Gao

Rapid inflation-deflation stenting vs. pressure optimisation protocol in primary PCI: RAPID-POP randomised controlled trial
急诊PCI 中快速充-放气支架植入 vs. 压力优化方案：RAPID-POP 随机对照试验

Transcatheter mitral interventions: outcomes and new procedural approaches

北京时间：5月20日 15:45-16:45

Surgical vs. TEER for secondary mitral regurgitation: a meta-analysis
外科手术 vs. TEER 治疗继发性二尖瓣反流：荟萃分析

Transcatheter vs. surgical repeat mitral replacement for failed bioprosthetic mitral valve
经导管 vs. 外科再次二尖瓣置换用于衰败的生物瓣

Clinical outcomes of transfemoral TAVR
经股动脉 TAVR 的临床结局

Real-world safety and efficacy of transeptal TMVR
经房间隔 TMVR 的真实世界安全性与有效性

A multicentre registry of transeptal BATMAN to prevent left ventricular outflow tract obstruction during TMVR
经房间隔BATMAN预防TMVR期间左心室流出道梗阻的多中心注册研究

New devices for structural interventions

北京时间：5月20日 15:45-16:45

Thirty-day outcomes of balloon-expandable TAVI for aortic stenosis: Encantor Early Feasibility Study
球囊扩张式 TAVI 治疗主动脉瓣狭窄的 30 天结局：Encantor 早期可行性研究

Outcomes of percutaneous mechanical aspiration for left-sided infective endocarditis
经皮机械抽吸治疗左侧感染性心内膜炎的结局

The Trisol TTVR system technology and early feasibility study update
Trisol TTVR 系统技术及早期可行性研究更新

Laplace TTVR system early feasibility study
Laplace TTVR 系统早期可行性研究

Multicenter evaluation of a TEER system in high-risk patients with degenerative mitral regurgitation
TEER 系统用于高危退行性二尖瓣反流患者的多中心评估
北部战区总医院 韩雅玲院士

TAVI: head-to-head trials

北京时间：5月20日 15:45-16:45

Three-year outcomes of the SMART trial

SMART 试验的三年结局

Two-year outcomes of contemporary TAVI valves: LANDMARK, a randomised, non-inferiority trial
当代 TAVI 瓣膜的两年结局：LANDMARK 随机非劣效性试验

Outcomes after TAVI with latest-generation intra- and supra-annular self-expanding valves
新一代环内与环上自膨胀瓣膜 TAVI 术后结局

TAVI in large annuli: Myval vs. Evolut R
大瓣环患者中的 TAVI：Myval vs. Evolut R

ALL WOMEN: multicentre randomised clinical trial ALLEGRA vs. balloon-expandable valve in women
ALL WOMEN：ALLEGRA vs. 球囊扩张式瓣膜用于女性的多中心随机临床试验

Sham Controlled Randomised Trial Evaluating the Safety, Acceptability and Efficacy of Autonomic Neuromodulation Using Trans-Cutaneous Vagal Sensory Stimulation in Uncontrolled Hypertensive Patients
低危年轻主动脉瓣狭窄患者 TAVI vs. 外科 AVR 后的健康状况：NOTION-2 子分析

New data in DCB outcomes

北京时间：5月20日 17:15-18:15

Intravascular lithotripsy plus DCB in calcified small coronary vessels
血管内碎石联合药物涂层球囊治疗钙化小冠状动脉血管

Outcomes of OCT-guided PCI with DCB: insights from a real-world registry
OCT 指导的 PCI 联合药物涂层球囊的结局：真实世界注册研究见解

Predictors of angiographic outcomes after sirolimus-coated balloon angioplasty for de novo coronary artery disease
西罗莫司涂层球囊血管成形术治疗 de novo 冠状动脉疾病的血管造影结局预测因素

Practice change with DCB in patients with multivessel coronary artery disease
药物涂层球囊在多支冠状动脉疾病患者中的实践转变

12-month clinical results after crystalline-sirolimus-coated balloon angioplasty
结晶型西罗莫司涂层球囊血管成形术的 12 个月临床结果

New evidence for the use of DCB

北京时间：5月20日 21:00-22:00

Sirolimus eluting balloon in complex PCI: evidence from the SELUTION De Novo trial
复杂 PCI 中西罗莫司洗脱球囊的应用：SELUTION De Novo 试验证据

Vascular healing at bifurcation after side-branch drug-coated vs. conventional balloon: OCT study
分叉病变边支药物涂层球囊 vs. 普通球囊后的血管愈合情况：OCT 研究

Angiographic patterns of restenosis following DCB angioplasty for de novo coronary lesions
药物涂层球囊血管成形术治疗 de novo 冠状动脉病变后支架内再狭窄的血管造影模式

Long-term outcomes of DCB angioplasty vs. DES implantation for small vessel coronary artery disease
药物涂层球囊血管成形术 vs. 药物洗脱支架植入术治疗小血管冠状动脉疾病的长期结局

Coronary bifurcation lesions side branch optimal treatment study: the BILBO multicentre study
冠状动脉分叉病变边支最佳治疗研究：BILBO 多中心研究

New evidence for coronary physiology in epicardial disease

北京时间：5月20日 21:00-22:00

Individual patient data analysis of the DEFINE-FLAIR and iFR-SWEDEHEART trials: five-year follow-up
DEFINE-FLAIR 和 iFR-SWEDEHEART 试验的个体患者数据分析：五年随访

Complete revascularisation in elderly patients with myocardial infarction with or without diabetes
伴或不伴糖尿病的老年心肌梗死患者的完全血运重建

Impact of intravascular imaging-guided PCI on one-year clinical outcomes in focal vs. diffuse coronary artery disease
血管内成像指导的 PCI 对局灶性 vs. 弥漫性冠状动脉疾病一年临床结局的影响

Prognostic implications of coronary CT angiography-derived physiology and plaque features in patients referred for ICA
冠状动脉 CT 血管成像衍生的生理学与斑块特征对转诊 ICA 患者的预后意义
上海交通大学 涂圣贤教授

Angiography-derived vs. pressure wire-based assessment in the left anterior descending coronary artery: a subgroup analysis of the ALL-RISE randomized trial
血管造影衍生的 vs. 压力导丝评估用于左前降支：ALL-RISE 随机试验的亚组分析

Advancing TAVI practice

北京时间：5月21日 15:45-16:45

Aspirin vs. clopidogrel as single antiplatelet therapy after TAVI
阿司匹林 vs. 氯吡格雷作为 TAVI 术后单抗血小板治疗

Treatment of pure aortic regurgitation with a dedicated transcatheter heart valve vs. surgery: first results of EROICA
专用经导管心脏瓣膜 vs. 外科手术治疗单纯主动脉瓣反流：EROICA 首次结果

Early hemodynamic valve deterioration as a new prognostic marker after TAVI
早期血流动力学瓣膜退化作为 TAVI 术后新的预后标志物

Prosthesis-patient mismatch following redo-TAVI: insights from the prospective ReTAVI registry
再次 TAVI 后的人工瓣膜-患者不匹配：前瞻性 ReTAVI 注册研究的见解

First-in-human transcatheter valve-in-mechanical valve using disc dislodgement and extraction
首次人体经导管瓣中瓣技术用于机械瓣（通过瓣片脱位并取出）

First large comprehensive core-lab evaluation of implantation depth and clinical outcomes in TAVI
首个大型核心实验室评估 TAVI 植入深度与临床结局

TAVI - Procedural strategy

北京时间：5月21日 15:45-16:45

The impact of coronary artery disease severity on PCI decision-making in patients undergoing TAVI
冠状动脉疾病严重程度对接受 TAVI 患者 PCI 决策的影响

Coronary revascularisation strategies in high-bleeding risk patients undergoing TAVI
接受 TAVI 的高出血风险患者的冠状动脉血运重建策略

CT quality and implant depth in TAVI: membranous septum length in the optimise PRO study
TAVI 中的 CT 质量与植入深度：optimise PRO 研究中室间隔膜部长度

Pre-dilatation vs. direct valve implant for TAVI with balloon-expandable valve in Sievert Type 1 bicuspid aortic valve
球囊扩张式瓣膜用于 Sievert 1 型二叶式主动脉瓣 TAVI：预扩张 vs. 直接瓣膜植入

Vascular control in TAVI

TAVI 中的血管控制

New evidence for coronary revascularisation

北京时间：5月21日 17:00-18:00

CT-derived virtual stenting to optimise revascularisation: one-year follow-up of CT-COMPASS trial
CT 衍生虚拟支架植入优化血运重建：CT-COMPASS 试验的一年随访
中国医学科学院阜外医院 窦克非教授

A randomised evaluation of left ventricular unloading in complex percutaneous coronary intervention
复杂经皮冠状动脉介入治疗中左心室卸负荷的随机评估

Ten-year outcomes of FFR-guided PCI vs. medical therapy in stable coronary artery disease: reconstructed IPD meta-analysis
FFR 指导的 PCI vs. 药物治疗稳定型冠状动脉疾病的十年结局：重建的个体患者数据荟萃分析

Left ventricular support with Impella CP in high-risk PCI: PROTECT-EU registry
高危 PCI 中 Impella CP 左心室支持：PROTECT-EU 注册研究

PCI vs. CABG in diabetic patients with multivessel disease: results from the TUXEDO 2 study
糖尿病多支血管病变患者 PCI vs. CABG：TUXEDO 2 研究结果

New data on intracoronary imaging-guided interventions

北京时间：5月21日 21:00-22:00

Two-year outcomes after angiography-derived FFR-guided and IVUS-guided PCI
血管造影衍生的 FFR 指导与 IVUS 指导 PCI 后的两年结局
浙江大学医学院附属第二医院 蒋峻教授

Comparison between OCT and IVUS for intermediate left main stenosis（EMPERATRIZ Epic 36 Study）
OCT 与 IVUS 用于左主干中度狭窄的比较（EMPERATRIZ Epic 36 研究）

High-risk non-culprit lesions and long-term clinical outcome after myocardial infarction
心肌梗死后高危非罪犯病变与长期临床结局

The role of coronary lipid burden in atherosclerotic non-culprit plaque regression
冠状动脉脂质负荷在动脉粥样硬化非罪犯斑块消退中的作用

Achievement of optimal revascularisation after IVI-guided PCI according to coronary artery disease patterns
根据冠状动脉疾病模式实现 IVI 指导 PCI 后最佳血运重建

New data on intracoronary imaging-guided interventions

北京时间：5月21日 22:15-23:15

Coronary endothelial dysfunction in patients with angina and non-obstructive coronary arteries
心绞痛伴非阻塞性冠状动脉患者的冠状动脉内皮功能障碍

Prognostic value of microvascular resistance reserve: a systematic review and meta-analysis
微血管阻力储备的预后价值：系统综述与荟萃分析

A prospective natural-history study of coronary microvascular disease
冠状动脉微血管疾病的前瞻性自然病史研究

Standardising the management of patients with coronary microvascular dysfunction: the SAMCRO trial
规范冠状动脉微血管功能障碍患者的管理：SAMCRO 试验

Angiography-derived index of microcirculatory resistance in older patients with ACS
血管造影衍生的微循环阻力指数在老年 ACS 患者中的应用

LAA closure and pulmonary embolism hotline

北京时间：5月22日 16:15-17:15

Device-related thrombus after LAA closure: clinical impact and management
左心耳封堵术后器械相关血栓：临床影响与处理

Device healing after LAA closure with a novel coated implant
新型涂层植入物左心耳封堵术后器械愈合情况

Mechanical thrombectomy vs. catheter-directed thrombolysis for pulmonary embolism: a meta-analysis
机械取栓 vs. 导管定向溶栓治疗肺栓塞：荟萃分析

Prognostic impact of hemodynamic data on clinical outcomes after pulmonary embolism thrombectomy
血流动力学数据对肺栓塞血栓切除术后临床结局的预后影响

上一篇： APASL2026丨“致远”项目阶段性成...

下一篇： EAS 2026丨三大Late Brea...